Overview

Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis

Status:
NOT_YET_RECRUITING
Trial end date:
2031-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate that a rifampin-free regimen is non-inferior to the rifampin-containing regimen in terms of all-cause mortality in staphylococcal prosthetic valve endocarditis within 6 months after randomization.
Phase:
PHASE3
Details
Lead Sponsor:
Nantes University Hospital